Search the Newsreel

Mitsubishi UFJ Asset Management Co. Ltd. Acquires Shares of 268,354 Quest Diagnostics Incorporated $DGX

Mitsubishi UFJ Asset Management Co. Ltd. has acquired a new stake of 268,354 shares in Quest Diagnostics Incorporated, valued at approximately $56.88 million, representing 0.24% of the company. Other institutional investors have also adjusted their holdings in DGX. Wall Street analysts have issued various …

REG - CRISM Therapeutics - Commencement of Patient Recruitment

Wealthfront Advisers LLC Makes New Investment in Quest Diagnostics Incorporated $DGX

Wealthfront Advisers LLC has made a new investment in Quest Diagnostics (NYSE:DGX), purchasing 34,789 shares valued at approximately $7.4 million in the second quarter. Institutional investors now own 88.06% of the company. Quest Diagnostics recently reported strong quarterly earnings, surpassing analyst estimates, and announced …

Earnings call transcript: VSTECS H1 2026 profit jumps 50% as shares fall

Wealthfront Advisers LLC Buys Shares of 160,086 CSX Corporation $CSX

Wealthfront Advisers LLC recently acquired 160,086 shares of CSX Corporation, valued at approximately $7.6 million, during the second quarter, contributing to institutional investors owning 73.57% of the company's stock. CSX reported strong Q2 earnings, exceeding analyst estimates with $0.54 EPS and $3.94 billion in …

China Infrastructure & Logistics Group in Five-Year Port Coatings Pact to Drive New Growth

Iovance Biotherapeutics (IOVA) Stock Could Be Rich Following Its 217% Run

Handelsbanken Fonder AB Buys New Shares in Enliven Therapeutics, Inc. $ELVN

Handelsbanken Fonder AB acquired 17,300 shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) valued at approximately $878,000 during the second quarter. Institutional investors and hedge funds now collectively own 95.08% of the company's stock, while insider transactions show sales totaling $11.3 million over the past 90 …

Form 144 | Veradermics(MANE.US) Insider Proposes to Sell 6.37 Million in Common Stocks

An insider at Veradermics (MANE.US) has filed a Form 144, indicating a proposal to sell 6.37 million common stocks. This filing provides notice of the individual's intent to sell a significant number of shares in the company.

Royal Bank of Canada Has $1.60 Million Stock Holdings in Dianthus Therapeutics, Inc. $DNTH

Royal Bank of Canada significantly increased its stake in Dianthus Therapeutics, Inc. by 847.5% in the first quarter, now holding 19,064 shares valued at $1.60 million. Despite the company missing EPS estimates, institutional investors collectively own 47.53% of the stock, and Wall Street analysts …

China Infrastructure & Logistics forecasts 225% profit surge on terminal-focused strategy

Radiopharm Theranostics Advances 177Lu-RAD202 to Cohort 4 in Phase 1 HEAT Clinical Trial

Radiopharm Theranostics (ASX:RAD) has received a positive recommendation from its Data Safety and Monitoring Committee to advance its radiotherapeutic asset 177Lu-RAD202 to the next dose level in the Phase 1 'HEAT' clinical trial. This advancement to Cohort 4, at a dose of 180mCi, is …

Handelsbanken Fonder AB Purchases Shares of 19,400 Structure Therapeutics Inc. Sponsored ADR $GPCR

Handelsbanken Fonder AB recently acquired 19,400 shares of Structure Therapeutics Inc. Sponsored ADR (GPCR) for approximately $1.04 million in the second quarter. Institutional investors now collectively own 91.78% of the company's stock. Despite missing earnings estimates in its last report, analysts have a "Moderate …

Telefonaktiebolaget LM Ericsson Class A Revenue Breakdown – OMXSTO:ERIC_A

Telefonaktiebolaget LM Ericsson Class A (OMXSTO:ERIC_A) generated a total revenue of 236.68 billion SEK last year. The Networks segment was the top performer, contributing 151.01 billion SEK, while the United States was the largest regional contributor with 96.47 billion SEK.

Eagle Health Investments LP Buys Shares of 166,148 Kymera Therapeutics, Inc. $KYMR

Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest Session - Annual Report

Allcargo Logistics accepts Shashi Kiran Shetty resignation as chairman

Integral Diagnostics (ASX:IDX): Capitol Health Integration and Margin Growth Remain Key Investor Themes

Why Nanosonics’ (ASX:NAN) Recurring Revenue Model Is Becoming Central to Its Healthcare Strategy?

31,882 Shares in Commerce Bancshares, Inc. $CBSH Purchased by First National Bank of Omaha

First National Bank of Omaha recently purchased 31,882 shares of Commerce Bancshares, Inc. (NASDAQ:CBSH) valued at approximately $1.85 million. Other institutional investors also adjusted their holdings in CBSH, while some company insiders sold shares. Analysts currently rate CBSH as "Hold" with a consensus target …

248,322 Shares in Protagonist Therapeutics, Inc. $PTGX Purchased by Eagle Health Investments LP

Eagle Health Investments LP has acquired 248,322 shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX) for approximately $30.44 million, making it their 8th largest position. Other institutional investors like BlackRock Inc. and Vanguard Group Inc. have also adjusted their holdings in PTGX. The article also notes …

Great Lakes Advisors LLC Invests $6.97 Million in Protagonist Therapeutics, Inc. $PTGX

Great Lakes Advisors LLC has acquired a new stake in Protagonist Therapeutics, Inc., purchasing 56,904 shares valued at approximately $6.98 million. This investment comes amidst significant institutional ownership of PTGX (98.63%) and generally favorable analyst sentiment, despite a recent downgrade by Zacks Research. Protagonist …

Great Lakes Advisors LLC Makes New $7.56 Million Investment in Home BancShares, Inc. $HOMB

Great Lakes Advisors LLC recently acquired a new position in Home BancShares, Inc. (NYSE:HOMB), purchasing 264,951 shares valued at approximately $7.56 million. This investment comes as Home BancShares exceeded earnings and revenue expectations in its last quarterly report and increased its quarterly dividend. Analysts …

Denali Advisors LLC Has $1.70 Million Stock Position in Photronics, Inc. $PLAB

Denali Advisors LLC significantly reduced its stake in Photronics, Inc. (NASDAQ:PLAB) by 59.3% in the second quarter, now holding 52,353 shares valued at approximately $1.70 million. This comes as Photronics faces investor uncertainty due to missed quarterly earnings and revenue expectations, and a securities …

CSW Industrials, Inc. (NYSE:CSW) Given Average Recommendation of "Moderate Buy" by Analysts

CSW Industrials (NYSE:CSW) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $347.57. The company recently reported strong quarterly earnings, beating estimates with $3.84 EPS and a 33% revenue increase to $350.65 million. Despite some insider sales, …

First Mid Bancshares, Inc. (NASDAQ:FMBH) Given Average Recommendation of "Moderate Buy" by Analysts

First Mid Bancshares, Inc. (NASDAQ:FMBH) has received a "Moderate Buy" consensus recommendation from analysts, with an average twelve-month target price of $54.6250. Several research firms have recently updated their ratings and price targets, generally increasing their objectives for the stock. Institutional investors have also …

Renaissance Technologies LLC Decreases Stock Position in Fulgent Genetics, Inc. $FLGT

Renaissance Technologies LLC significantly reduced its stake in Fulgent Genetics, Inc. by 78.3% in Q1 2026, selling 64,864 shares and retaining 18,000 shares valued at $286,000. This divestment follows Fulgent Genetics' weaker-than-expected quarterly results, including an adjusted loss of $0.58 per share and revenue …

Shield Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2026

Proficient (PAL) Financial Results: EPS Falls Short of Its Estimate for This Review; Trading Response: The Stock Ends Down 3.74% for the Current Session - One-Time Loss Impact

First (FCBC) Results Breakdown: The Bottom-Line Figure Beats Its Comparison; Market Move: Shares Finish 1.28% Down on the Day - Earnings Preview

Ovid Therapeutics Inc. (OVID) Stock Price, News, Quote & History

Cleo Diagnostics Ltd Reports Earnings Results for the Full Year Ended June 30, 2026

Astronics EVP gifts 150 shares, holds 62K common | ATRO Insider Trading

Astronics Corp (ATRO) Executive VP & President–Aerospace Mark Peabody gifted 150 shares of common stock on August 18, 2026. Following this gift, he still directly holds 62,232.73 common shares, 232,610 Class B shares, and numerous stock options and performance-based restricted stock units. The RSUs …

Qnity Electronics, Inc Stock Price Live, Charts & News

This article provides a live overview of Qnity Electronics, Inc. (Q) stock performance, displaying its current price, daily changes, and key financial metrics. It includes fundamental data such as market cap, PE ratio, dividend yield, and historical returns, along with quarterly balance sheet, income …

General Dynamics Corporation $GD Shares Sold by Danske Bank A S

Danske Bank A S reduced its stake in General Dynamics Corporation by 7.7% in the second quarter, selling 6,387 shares and now owning 76,377 shares valued at $27.06 million. Despite this, other institutional investors have increased their holdings, and 86.14% of the company's stock …

416,438 Shares in General Dynamics Corporation $GD Purchased by Deutsche Bank AG

Deutsche Bank AG has acquired a new stake of 416,438 shares in General Dynamics Corporation (NYSE:GD), valued at approximately $147.5 million, representing about 0.15% of the company's stock. Other institutional investors have also adjusted their positions in General Dynamics. Analyst ratings for GD currently …